Fundz

Limula secures $6.8M in a seed round led by LifeX Ventures to advance software development for affordable cell and gene therapy products.

PRIVATEMay 21, 2024

Amount Raised

$6.8 Million

Round Type

Seed

EpalingesBiotechnologyHealth CareTherapeutics

Investors

The Founders And Angel InvestorsW.A. De Vigier FoundationLichtsteiner FoundationOxford Seed FundZühlke VenturesVerve VenturesLife X Ventures

Description

Limula has raised a $6.8M seed round to lower costs of life-saving cell and gene therapy products. The money raised will be used to advance software development.

Quick answer

Limula raised $6.8 Million in a Seed round, dated May 21, 2024. Investors: The Founders And Angel Investors, W.A. De Vigier Foundation, Lichtsteiner Foundation, Oxford Seed Fund, Zühlke Ventures, Verve Ventures and Life X Ventures. Limula is based in Epalinges, Vaud, Switzerland.

How much did Limula raise?
Limula raised $6.8 Million in a Seed round on May 21, 2024.
Who invested in Limula?
The Founders And Angel Investors, W.A. De Vigier Foundation, Lichtsteiner Foundation, Oxford Seed Fund, Zühlke Ventures, Verve Ventures and Life X Ventures are named as investors in this round.
What does Limula do?
Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale.
Where is Limula based and how big is it?
Limula is based in Epalinges, Vaud, Switzerland.
Who are the decision-makers at Limula?
Fundz holds 1 contact at Limula. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Limula that raised within 45 days of this round, from Fundz verified event records.

  • Virpax Pharmaceuticals raised $2.5M on July 5, 2024.
  • NGM Bio raised $73M on July 5, 2024.
  • Beacon Therapeutics raised $170M (Series B) on July 3, 2024.
  • Cartesian Therapeutics, Inc. raised $130M on July 2, 2024.
  • N-Power Medicine raised $72M (Series B) on July 1, 2024.
  • Scorpion Therapeutics raised $126M on July 1, 2024.

Who to call at Limula, and when

A new round usually means Limula is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Limula raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Limula, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Limula. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Limula

Location

Epalinges, Vaud, Switzerland

About

Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Limula raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Limula's next move

See what Strategic adds

Limula raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.